期刊論文| 1. | Lemley, Mark A.、Risch, Michael、Sichelman, Ted、Wagner, R. Polk(2011)。Life after Bilski。Stanford Law Review，63，1315-1346。   |
| 2. | Merges, Robert P.(1999)。As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent System Reform。Berkeley Technology Law Journal，14。 |
| 3. | Risch, Michael(2008)。Everything is Patentable。Tennessee Law Review，75。 |
| 4. | Allison, John R.、Lemley, Mark A.、Schwartz, David L.(2014)。Understanding the Realities of Modern Patent Litigation。Texas Law Review，92。 |
| 5. | Eisenberg, Rebecca S.(2012)。Wisdom of the ages or dead-hand control? Patentable subject matter for diagnostic methods after in re Bilski。Case Western Reserve Journal of Law, Technology & the Internet，3，1-65。 |
| 6. | Rai, Arti Kaur(1999)。Regulating Scientific Research: Intellectual Property Rights and the Norms of Science。Northwestern University Law Review，94(1)，77-152。 |
| 7. | Sanger, Frederick、Niclen, Steve、Coulson, Alan R.(1977)。DNA sequencing with chain-terminating inhibitors。Proceedings of the National Academy of Sciences of the United States of America，74(12)，5463-5467。 |
| 8. | Borson, D. Benjamin(1994)。The Human Genome Projects: Patenting Human Genes and Biotechnology. Is the Human Genome Patentable?。IDEA: The Journal of Law and Technology，35(4)。 |
| 9. | Heller, Michael A.、Eisenberg, Rebecca S.(1998)。Can Patents Deter Innovation? The Anticommons in Biomedical Research。Science，280(5364)，698-701。 |
| 10. | Rai, Arti K.、Sherkow, Jacob S.(2016)。The Changing Life Science Patent Landscape。Nature Biotechnology，34(3)。 |
| 11. | Madigan, Kevin、Mossoff, Adam(2017)。Turning Gold Into Lead: How Patent Eligibility Doctrine is Undermining U.S. Leadership in Innovation。George Mason Law Review，24，939-960。 |
| 12. | Price, W. Nicholson II(2015)。Black-Box Medicine。Harvard Journal of Law & Technology，28(2)，419-467。 |
| 13. | Burk, Dan L.、Lemley, Mark A.(2003)。Policy Levers in Patent Law。Virginia Law Review，89(7)，1575-1696。 |
| 14. | Evans, Barbara J.(2014)。Economic regulation of next-generation sequencing。The Journal of Law, Medicine & Ethics，42，51-66。 |
| 15. | Leader, Benjamin(2008)。Protein Therapeutics: a Summary and Pharmacological Classification。Nature Reviews Drug Discovery，7(1)，21-39。 |
| 16. | Beauchamp, Christopher(2013)。Patenting Nature: A Problem of History。Stanford Technology Law Review，16，257-311。 |
| 17. | Adams, Christopher、Brantner, Van V.(2006)。Estimating the Cost of New Drug Development: Is It Really 802 Million?。Health Affairs，25(2)，420-428。 |
| 18. | Yarbrough, Daniel K.(2014)。After Myriad: Reconsidering the Incentives for Innovation in the Biotech Industry。Michigan Telecommunications and Technology Law Review，21。 |
| 19. | Robinson, Douglas、Medlock, Nina(2005)。Diamond v. Chakrabarty: A Retrospective on 25 Years of Biotech Patents。Intellectual Property and Technology Law Journal，17。 |
| 20. | Noorani, H. Z.(1996)。Cost Comparison of Molecular Versus Conventional Screening of Relatives at Risk for Retinoblastoma。American Journal of Human Genetics，59。 |
| 21. | Dolin, Gregory(2013)。Exclusivity Without Patents: The New Frontier of FDA Regulation for Genetic Materials。Iowa Law Review，98。 |
| 22. | Kane, Eileen M.(2011)。Patenting Genes and Genetic Methods: What's at Stake?。Journal of Business & Technology Law，6。 |
| 23. | Van Gieson, Edward、Stellman, Paul(2010)。Killing Good Patents to Wipe out Bad Patents: Bilski, the Evolution of Patentable Subject Matter Rules, and the Inability to Save Valuable Patents Using the Reissue Statute。Santa Clara High Technology Law Journal，27。 |
| 24. | Lefstin, Jeffrey A.、Menell, Peter S.、Taylor, David O.(2018)。Final Report of the Berkeley Center for Law & Technology Section 101 Workshop: Addressing Patent Eligibility Challenges。Berkeley Technology Law Journal，33。 |
| 25. | Golden, John M.(2001)。Biotechnology, Technology Policy, and Patentability: Natural Products and Invention in the American System。Emory Law Journal，50。 |
| 26. | Strandburg, Katherine J.(2012)。Much Ado About Preemption。Houston Law Review，50。 |
| 27. | Carrier, Michael A.(2002)。Unraveling the Patent-Antitrust Paradox。University of Pennsylvania Law Review，150(3)。 |
| 28. | Sikora, Mike(2018)。Mayo, myriad, and a muddled analysis: Do recent changes to the patentable subject matter doctrine threaten patent protections for epigenetics-based inventions?。Minnesota Law Review，102(5)，2229-2268。 |
| 29. | Sigareva, Marina A.、O'Donnell, Ryan W.(2017)。Global Strategies for Protecting Inventions in the Biotechnology Sector。New Jersey Law Journal，307。 |
| 30. | Andrews, Lori B.(2002)。Genes and Patent Policy: Rethinking Intellectual Property Rights。George Mason Law Review，3。 |
| 31. | Tudhope, Nicole(2018)。Misunderstanding Biotechnology: Separating Laws of Nature From Underlying Technological Developments。Willamette Law Review，54。 |
| 32. | Milunsky, Aubrey(1993)。The New Genetics: From Research to Reality。Suffolk University Law Review，27，1307-1325。 |
| 33. | Gugliuzza, Paul R.(2019)。The Procedure of Patent Eligibility。Texas Law Review，97。 |
| 34. | Gugliuzza, Paul R.、Lemley, Mark A.(2018)。Can a Court Change the Law by Saying Nothing?。Vanderbilt Law Review，71。 |
| 35. | Peace, N.、Christie, A.(1986)。Intellectual Property Protection for the Products of Animal Breeding。European Intellectual Property Review，18(4)，213-233。 |
| 36. | Eisenberg, Rebecca S.(2000)。Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences。Emory Law Journal，49。 |
| 37. | Feldman, Robin、Price, W. Nicholson II(2014)。Patent Trolling: Why Bio & Pharmaceuticals Are at Risk。Stanford Technology Law Review，2，773-805。 |
其他| 1. | U.S. Patent & Trademark Office(2017)。Comments of the Pharmaceutical Research and Manufacturers of America，https://www.uspto.gov.sites/default/f51es/documents/RT2%20Comments%20PhRMA.pdf。 |
| 2. | (20140214)。Ariosa's prenatal test gains crucial New York lab licensing certification，http://www.fiercediagnostics.com/story/ariosas-prenataI-test-gains-crucial-new-york-lab-licensing-certification/2014-02-14。 |
| 3. | Gold, Ashley。Lee Staying on as Patent Chief Under Trump Administration，http://www.politico.com/blogs/donald-trump-administration/2017/01/michelle-Iee-patent-offlce-chief-to-stay-on-233847。 |
| 4. | Lee, Christopher(20070528)。Slump in NIH Funding is Taking Toll on Research，http://www.washingtonpost.com/wp-dyn/content/article/2007/05/27/AR2007052700794.html。 |
| 5. | Tysver, Daniel A.(2019)。Are Software and Business Methods Still Patentable After the Bilski Decision?，http://www.bitlaw.com/software-patent/bilski-and-software-patents.html。 |
| 6. | Quinn, Gene。SCOTUS Rules Alice Software Claims Patent Ineligible，http://www.ipwatchdog.com/2014/06/19/scotus-rules-alice-software-claims-patent-ineligible。 |
| 7. | Angier, Natalie(19940920)。Fierce Competition Marked Fervid Race for Cancer Gene，http://www.nytimes.com/1994/09/20/science/fierce-competition-marked-fervid-race-for-cancer-gene.html?pagewanted=all。 |
| 8. | Foroohar, Rana(20170903)。A Better US Patent System Will Spur Innovation，https://www.ft.com/content/74114a6c-8f28-1Ie7.9084-d0cl7942ba93?mhq5j=e6。 |
| 9. | Plotkin, Robert。Software Patents are Only as Dead as Schr6dinger's Cat，http://www.ipwatchdog.com/2014/10/06/software-patents-are-only-as>dead-as-schrodingers-cat。 |
| 10. | Sachs, Robert R.。The One Year Anniversary: The Aftermath of Alice Strom，http://www.bilskiblog.com/blog/2015/06/the-one-year-anniversary-the-aftermath-of-alicestomi.html。 |
| 11. | Callahan, Steven。Alice: The Death of Software-Related Patents?，http://www.ndtexblog.com/?p=3550。 |